Investors

Releases

20.11.2024

The commercialization of Bioretec’s RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement

Press release
14.11.2024

Bioretec Ltd’s business review January–September 2024: Launch of the RemeOs™ Trauma Screw in the U.S. is proceeding to the next phase, EU authorization in the final stage

Company announcement
04.10.2024

Inside information: Bioretec updates its financial targets

Company announcement
04.10.2024

Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs™ Spinal Interbody Cage

Company announcement
20.09.2024

Bioretec’s Shareholders' Nomination Board appointed

Company announcement
15.08.2024

Bioretec Ltd’s half-year report January–June 2024: RemeOs™ trauma screw controlled launch in the U.S. yielded expected positive clinical results

Company announcement
27.06.2024

Inside Information: Update for Bioretec's RemeOs™ Trauma Screw European Marketing Authorization

Company announcement
19.06.2024

Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs™ trauma screw: fracture healing confirmed in 100% of surgical procedures

Press release
18.06.2024

Bioretec Appoints Frank Sarcone as Vice President of Sales for the US and a member of the Management Team

Press release
21.05.2024

Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings - Ilmarinen Mutual Pension Insurance Company

Company announcement

Releases

Enhance your Specialist experience with Bioretec app!

Add Bioretec to your home screen

Releases

Enhance your Specialist experience with Bioretec app!

Add Bioretec to your home screen

Notification settings